Glypican 2

Glypican 2 분자 정보

영어 이름Glypican-2시판 약물 수0
임상 약물 수2표적 별명Cerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
최고 연구 개발 단계Phase 1 Clinical
영어 이름Glypican-2
표적 별명Cerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 1 Clinical

Glypican 2 제품 목록

  • 속성

    Protein (7)

  • 제품 라이브러리

    온라인 (7)

  • Human (4)Mouse (1)Rhesus macaque (2)

  • 태그

    His Tag (3)Fc Tag (1)Llama IgG Fc Tag (1)His Tag & Avi Tag (2)

  • 마커

    Unconjugated (5)Biotin-labeled (2)

Glypican 2분자 배경

Glypican 2 (GPC2), also known cerebroglycan, is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons. Cerebroglycan has especially high affinity for laminin-1. GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models. A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.

Glypican 2분자 별명

Glypican 2,GPC2

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma)Phase 1 ClinicalChildrens Hospital of PhiladelphiaRhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
상세
GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics)TmGPC2-01-CAR-TPhase 1 ClinicalChildrens Hospital of PhiladelphiaSmall Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호